Cytarabine (Cytarabine): Uses, Dosage, Side Effects, Interactions, Warning
![UPCM 2022さんはTwitterを使っています: 「[Pharma Nugget] Hi, Class 2022! Here's your daily Knowledge Nugget™! #Pharmacology #PharmasMagetsNatin #SmarTherEveryday #BSEReady #ExamReady https://t.co/celU06XWMD」 / Twitter](https://pbs.twimg.com/media/EEB3-InVUAAP0wU.jpg "UPCM 2022さんはTwitterを使っています: 「[Pharma Nugget] Hi, Class 2022! Here's your daily Knowledge Nugget™! #Pharmacology #PharmasMagetsNatin #SmarTherEveryday #BSEReady #ExamReady https://t.co/celU06XWMD」 / Twitter")
UPCM 2022さんはTwitterを使っています: 「[Pharma Nugget] Hi, Class 2022! Here's your daily Knowledge Nugget™! #Pharmacology #PharmasMagetsNatin #SmarTherEveryday #BSEReady #ExamReady https://t.co/celU06XWMD」 / Twitter
7+3 (daunorubicin) for AML | ChemoExperts
Cytarabine (Ara C, cytosine arabinoside)
Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG | Leukemia
Cytotoxic T lymphocytes promote cytarabine-induced acute myeloid leukemia cell apoptosis via inhibiting Bcl-2 expression
Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports
PDF) Bilateral Ear Swelling and Erythema after Chemotherapy: A Case Report of Ara-C Ears
Cellular Intrinsic Mechanism Affecting the Outcome of AML Treated with Ara-C in a Syngeneic Mouse Model | PLOS ONE
Bilateral Ear Swelling and Erythema after Chemotherapy: A Case Report of Ara -C Ears | Semantic Scholar
GLI1 reduces drug sensitivity by regulating cell cycle through PI3K/AKT/GSK3/CDK pathway in acute myeloid leukemia | Cell Death & Disease
Cytarabine chemotherapy, uses, dose & cytarabine side effects
Prevention and Treatment of Cytarabine-Induced Keratoconjunctivitis
Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy | Journal of Experimental & Clinical Cancer Research | Full Text
Acute myeloid leukemia—Major progress over four decades and glimpses into the future - Kantarjian - 2016 - American Journal of Hematology - Wiley Online Library
X‐linked inhibitor of apoptosis inhibition sensitizes acute myeloid leukemia cell response to TRAIL and chemotherapy through potentiated induction of proapoptotic machinery - Zhou - 2018 - Molecular Oncology - Wiley Online Library
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial - The Lancet
Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy | EMBO Molecular Medicine
Dose intensity for induction in acute myeloid leukemia: what, when, and for whom? | Haematologica
Cancers | Free Full-Text | Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers | HTML
Chemotherapy of acute leukemia with ara-C Estimated ara-C plasma... | Download Table
Cytarabine - Wikiwand
Cancer Treatment–Induced Arrhythmias | Circulation: Arrhythmia and Electrophysiology
Chemotherapy-induced differential cell cycle arrest in B-cell lymphomas affects their sensitivity to Wee1 inhibition | Haematologica
Chemotherapy treatment Black and White Stock Photos & Images - Alamy
Valproic acid enhances the antileukemic effect of cytarabine by triggering cell apoptosis
